Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients
- PMID: 33610193
- PMCID: PMC7906709
- DOI: 10.1016/S0140-6736(21)00448-7
Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients
Comment in
-
COVID-19 vaccine efficacy data: solid enough to delay second dose?Lancet. 2021 Jun 12;397(10291):2248-2249. doi: 10.1016/S0140-6736(21)01046-1. Lancet. 2021. PMID: 34119060 Free PMC article. No abstract available.
Similar articles
-
The COVID-19 pandemic and face shields.Br J Surg. 2020 Sep;107(10):e398. doi: 10.1002/bjs.11842. Epub 2020 Jul 31. Br J Surg. 2020. PMID: 32735688 Free PMC article. No abstract available.
-
COVID-19 in Turkey: a nation on edge.Lancet. 2021 May 15;397(10287):1794-1796. doi: 10.1016/S0140-6736(21)01098-9. Lancet. 2021. PMID: 33992132 Free PMC article. No abstract available.
-
Protecting healthcare workers: A critical part of the COVID-19 response.S Afr Med J. 2020 Oct 23;110(12):1154-1155. doi: 10.7196/SAMJ.2020.v110i12.15048. S Afr Med J. 2020. PMID: 33403955 No abstract available.
-
COVID-19 vaccines and decreased transmission of SARS-CoV-2.Inflammopharmacology. 2021 Oct;29(5):1357-1360. doi: 10.1007/s10787-021-00847-2. Epub 2021 Jul 19. Inflammopharmacology. 2021. PMID: 34279767 Free PMC article. Review.
-
[SARS-CoV-2 vaccines].Ugeskr Laeger. 2021 Mar 8;183(10):V01210052. Ugeskr Laeger. 2021. PMID: 33734065 Review. Danish.
Cited by
-
Population immunity and vaccine protection against infection.Lancet. 2021 May 8;397(10286):1685-1687. doi: 10.1016/S0140-6736(21)00870-9. Epub 2021 Apr 23. Lancet. 2021. PMID: 33901422 Free PMC article. No abstract available.
-
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021.MMWR Morb Mortal Wkly Rep. 2021 Apr 2;70(13):495-500. doi: 10.15585/mmwr.mm7013e3. MMWR Morb Mortal Wkly Rep. 2021. PMID: 33793460 Free PMC article.
-
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccine-Breakthrough Infection Phenotype Includes Significant Symptoms, Live Virus Shedding, and Viral Genetic Diversity.Clin Infect Dis. 2022 Mar 9;74(5):897-900. doi: 10.1093/cid/ciab543. Clin Infect Dis. 2022. PMID: 34117878 Free PMC article.
-
COVID-19 vaccine efficacy data: solid enough to delay second dose?Lancet. 2021 Jun 12;397(10291):2248-2249. doi: 10.1016/S0140-6736(21)01046-1. Lancet. 2021. PMID: 34119060 Free PMC article. No abstract available.
-
Adherence and sustainability of interventions informing optimal control against the COVID-19 pandemic.Commun Med (Lond). 2021 Dec 6;1(1):57. doi: 10.1038/s43856-021-00057-5. Commun Med (Lond). 2021. PMID: 36759565
References
-
- Public Health England Annex A: Report to JCVI on estimated efficacy of a single dose of Pfizer BioNTech (BNT162b2 mRNA) vaccine and of a single dose of ChAdOx1 vaccine (AZD1222) Dec 22, 2020. https://assets.publishing.service.gov.uk/government/uploads/system/uploa...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous